Completed Study of ARO-APOC3 (Plozasiran) in Adults With Familial Chylomicronemia Syndrome (FCS) NCT05089084 Conditions Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dyslipidemias, Familial Chylomicronemia, +9 more Locations Clinical Site 1 — Boca Raton, Florida, United States Clinical Site 2 — Suwanee, Georgia, United States Clinical Site 3 — Indianapolis, Indiana, United States Clinical Site 4 — Elkridge, Maryland, United States View all 58 locations View more locations Show fewer locations Loading locations... View Trial Details
Completed Study of ARO-APOC3 in Healthy Volunteers, Hypertriglyceridemic Patients and Patients With Familial Chylomicronemia Syndrome (FCS) NCT03783377 Conditions Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dyslipidemias, Familial Chylomicronemia, +10 more Locations Research Site 2 — Camperdown, New South Wales, Australia Research Site 5 — Sippy Downs, Queensland, Australia Research Site 3 — Adelaide, South Australia, Australia Research Site 4 — Perth, Washington, Australia View more locations Show fewer locations Loading locations... View Trial Details
Completed Baby Detect : Genomic Newborn Screening NCT05687474 Conditions 3-Hydroxy 3-Methyl Glutaric Aciduria, 3-Hydroxy-3-Methylglutaryl-CoA Lyase Deficiency, 3-Hydroxy-3-Methylglutaryl-CoA Synthase 2 Deficiency, +368 more Locations CRMN, Hôpital La Citadelle — Liège, Wallonia, Belgium View Trial Details
